FIWBX
Price
$15.63
Change
+$0.11 (+0.71%)
Updated
Sep 15 closing price
Net Assets
3.01B
RLBCX
Price
$38.39
Change
+$0.07 (+0.18%)
Updated
Sep 15 closing price
Net Assets
263.06B
Interact to see
Advertisement

FIWBX vs RLBCX

Header iconFIWBX vs RLBCX Comparison
Open Charts FIWBX vs RLBCXBanner chart's image
Fidelity Advisor Multi-Asset Income Z
Price$15.63
Change+$0.11 (+0.71%)
VolumeN/A
Net Assets3.01B
American Funds American Balanced R3
Price$38.39
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets263.06B
FIWBX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIWBX vs. RLBCX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIWBX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 263B vs. FIWBX (3.01B). FIWBX pays higher dividends than RLBCX: FIWBX (3.84) vs RLBCX (1.53). FIWBX was incepted earlier than RLBCX: FIWBX (7 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than FIWBX (0.74). FIWBX is a more actively managed with annual turnover of: 230.00 vs. RLBCX (44.00). FIWBX has a lower initial minimum investment than RLBCX: FIWBX (0) vs RLBCX (250). FIWBX annual gain was more profitable for investors over the last year : 14.20 vs. RLBCX (9.50). FIWBX return over 5 years is better than : 53.86 vs. RLBCX (40.28).
FIWBXRLBCXFIWBX / RLBCX
Total Expense Ratio0.740.8983%
Annual Report Gross Expense Ratio0.740.8983%
Fund Existence7 years23 years-
Gain YTD12.92413.07199%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.01B263B1%
Annual Yield % from dividends3.841.53250%
Returns for 1 year14.209.50150%
Returns for 3 years38.7842.1492%
Returns for 5 years53.8640.28134%
Returns for 10 yearsN/A76.06-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WNC11.370.20
+1.79%
Wabash National Corp
NGVT58.690.54
+0.93%
Ingevity Corp
APVO1.44-0.03
-2.04%
Aptevo Therapeutics Inc
INCR1.53-0.04
-2.40%
Intercure Ltd
BAH101.62-3.00
-2.87%
Booz Allen Hamilton Holding Corp